Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
37 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Transgenomic, Inc. (Transgenomic) is a biotechnology company that offers personalized medicine in oncology, cardiology, neurology, and inherited diseases. The companys products include ICEme Kits, and genetic assays and platforms. Its offers genetic assays and platforms such as chromatography, hanabi cytogenetic systems, genetic analysis kits, PCR reagents, tissue microarray platforms and WAVE DHPLC systems. Transgenomic provides specimen collection kits which include cardiology kits, neurology kits, oncology kits, pharmacogenomic kits, scoliscore AIS prognostic kits and Whole Exome sequencing kits.

Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a su

  
Source:
Document ID
GDPH55065D
Country
Industry
Ticker
TBIO=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Transgenomic, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Transgenomic, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Transgenomic, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Transgenomic, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Transgenomic, Inc., Medical Devices Deals, 2010 to YTD 201691
Transgenomic, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Transgenomic, Inc., Pharmaceuticals &Healthcare, Deal Details1123
  Asset Purchase111
    Transgenomic To Acquire Clinical Sample Biorepository Assets From Gene Logic For US$0.3 Million111
    Transgenomic Completes Acquisition Of Diagnostic Business From Clinical Data122
  Partnerships141
    Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio142
    Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test161
    Transgenomic Enters Into Co-Development Agreement With Medical College of Wisconsin171
  Licensing Agreements181
    LabCorp Enters into Licensing Agreement with Transgenomic181
    Transgenomic Expands Licensing Agreement with Exiqon191
    Transgenomic Enters Into Licensing Agreement With Montefiore Medical201
  Equity Offering211
    Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares212
    Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant232
    Transgenomic to Raise USD3 Million in Private Placement251
    Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants262
    Transgenomic Raises USD7 Million in Private Placement of Shares281
    Transgenomic Completes Private Placement Of Shares For US$8 Million291
    Transgenomic Completes Private Placement Of Shares For US$19 Million302
    Transgenomic Completes Private Placement Of Series A Convertible Preferred Stock For US$6 Million322
Transgenomic, Inc. - Key Competitors341
Key Employees351
Locations And Subsidiaries361
  Head Office361
  Other Locations &Subsidiaries361
Appendix371
  Methodology371
  About GlobalData371
  Contact Us371
  Disclaimer371

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transgenomic-Inc-TBIO-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13963>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Transgenomic, Inc. (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transgenomic-Inc-TBIO-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13963>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research